Although no cause of death or further details were given, the news comes months after Lynch announced he had been living with emphysema. In an August 2024 interview with Sight and Sound magazine, ...

Moderna provides updates on its business and pipeline progress at the J.P. Morgan Healthcare Conference.

Leerink Partners analyst Joseph Schwartz has maintained their bullish stance on MREO stock, giving a Buy rating on January 13.Stay Ahead of ...

Michael Shaw, aged 24, of Bride Street, Todmorden is due to appear at Bradford magistrates' court today (Tuesday) charged ...

Financial writer recommends buying Intellia Therapeutics, Inc. stock as it restructures, focusing on late-stage programs for ...

Korro Bio (KRRO) announced the initiation of dosing in its REWRITE study investigating KRRO-110 as a potential treatment for individuals with ...

Cambridge, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing ...

The biotech plans to use the funding to advance clinical testing of an epigenetic silencing therapy it hopes could treat ...

Orbit Phase 3 study of setrusumab in osteogenesis imperfecta continuing to planned second interim analysis, expected in mid-2025 Alvelestat, for Alpha-1 Antitrypsin Deficiency-associated Lung Disease ...

Orbit Phase 3 study of setrusumab in osteogenesis imperfecta continuing to planned second interim analysis, expected in mid-2025 Alvelestat ...

Wells Fargo lowered the firm’s price target on Intellia Therapeutics (NTLA) to $60 from $70 and keeps an Overweight rating on ...

Shares of gene editing companies dropped on Friday as Wall Street reacted to Intellia Therapeutics' (NASDAQ:NTLA) plans to ...